HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 292/2/G647    most recent 00183.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Moeser, A. J. Articles by Blikslager, A. T. Search for Related Content PubMed PubMed Citation Articles by Moeser, A. J. Articles by Blikslager, A. T.

MUCOSAL BIOLOGY

Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone

¹Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina; and ²Sucampo Pharmaceuticals, Incorporated, Bethesda, Maryland

Submitted 1 May 2006 ; accepted in final form 11 October 2006

Previous studies utilizing an ex vivo porcine model of intestinal ischemic injury demonstrated that prostaglandin (PG)E₂ stimulates repair of mucosal barrier function via a mechanism involving Cl^– secretion and reductions in paracellular permeability. Further experiments revealed that the signaling mechanism for PGE₂-induced mucosal recovery was mediated via type-2 Cl^– channels (ClC-2). Therefore, the objective of the present study was to directly investigate the role of ClC-2 in mucosal repair by evaluating mucosal recovery in ischemia-injured intestinal mucosa treated with the selective ClC-2 agonist lubiprostone. Ischemia-injured porcine ileal mucosa was mounted in Ussing chambers, and short-circuit current (I_sc) and transepithelial electrical resistance (TER) were measured in response to lubiprostone. Application of 0.01–1 µM lubiprostone to ischemia-injured mucosa induced concentration-dependent increases in TER, with 1 µM lubiprostone stimulating a twofold increase in TER (TER = 26 ·cm²; P < 0.01). However, lubiprostone (1 µM) stimulated higher elevations in TER despite lower I_sc responses compared with the nonselective secretory agonist PGE₂ (1 µM). Furthermore, lubiprostone significantly (P < 0.05) reduced mucosal-to-serosal fluxes of ³H-labeled mannitol to levels comparable to those of normal control tissues and restored occludin localization to tight junctions. Activation of ClC-2 with the selective agonist lubiprostone stimulated elevations in TER and reductions in mannitol flux in ischemia-injured intestine associated with structural changes in tight junctions. Prostones such as lubiprostone may provide a selective and novel pharmacological mechanism of accelerating recovery of acutely injured intestine compared with the nonselective action of prostaglandins such as PGE₂.

ischemia; type 2 chloride channels; repair

This article has been cited by other articles:

				V. G. Romanenko, T. Nakamoto, M. A. Catalan, M. Gonzalez-Begne, G. J. Schwartz, Y. Jaramillo, F. V. Sepulveda, C. D. Figueroa, and J. E. Melvin Clcn2 encodes the hyperpolarization-activated chloride channel in the ducts of mouse salivary glands Am J Physiol Gastrointest Liver Physiol, November 1, 2008; 295(5): G1058 - G1067. [Abstract] [Full Text] [PDF]